TMCNet:  Markets and Markets : High Content Screening Market worth $615.8 Million by 2018

[October 13, 2014]

Markets and Markets : High Content Screening Market worth $615.8 Million by 2018

(M2 PressWIRE Via Acquire Media NewsEdge) The "High Content Screening Market by Instruments (Cell Imaging and Analysis System) by Applications (Primary and Secondary Screening, Target Identification and Validation, Toxicity Studies, Compound Profiling), Software & Services - Global Forecasts to 2018" analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia, and the Rest of the World (RoW).

Browse more than 50 market data tables with 10 figures spread through 151 pages and in-depth TOC on "High Content Screening Market" http://www.marketsandmarkets.com/Market-Reports/high-content-screening-market-42710391.html Early buyers will receive 10% customization on this report In recent years, the adoption of High Content Screening in various phases of drug discovery has increased. The global market was valued at $362.2 million in 2013 and is expected to reach $615.8 million by 2018, at a CAGR of 11.2%. The market is broadly classified based on products, applications, end users, and geographies.

The product market is further divided into instruments, consumables, software, and services. The instruments market is sub-divided into cell imaging and analysis systems and flow cytometers. The consumables market is further segmented into reagents and assay kits, microplates, and other consumables. The software market includes the market for image analysis and data management software. The services market includes screening services such as primary screening and secondary screening, services related to target identification and validation, toxicity studies, and compound profiling.

Get PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=42710391 The applications market includes primary screening and secondary screening, target identification and validation, toxicity studies, compound profiling and other applications. High content screening can be applied in both primary and secondary screening, although it is extensively used for the secondary screening process. In target identification, HCS is used to identify novel targets through the screening of cellular pathways. HCS can also provide more accurate information related to drug toxicity and mode of actions that helps in further decision making and helps to drive the progress of drug discovery. The other application of HCS is in studying cell signaling pathways. The primary and secondary screening market dominated the high content screening applications market, with a market share of 50% in 2013.

The major factors driving the growth of the market include the need for determining the level of toxicity in the early stages of drug discovery pipeline, government support for cell-based research, and the introduction of enhanced informatics solutions and improved image analysis instruments. Moreover, the adoption of HCS for primary screening and its application in the development of personalized medicine are key growth opportunities in this market.

Inquiry Before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=42710391 The global market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). North America will continue to lead the global market in the forecast period, followed by Europe. Over the next five years, the growth of the global market in the Asian region is likely to be centered on China, Japan, Singapore, and India. This growth will be driven by government support for the growth of innovative technologies and the rising demand for outsourcing of drug discovery services.

The major players in the market include Thermo Fisher Scientific (U.S.), Molecular Devices (acquired by Danaher Corporation) (U.S.), PerkinElmer, Inc. (U.S.), GE Healthcare (U.K.), Becton, Dickinson and Company (U.S.), Cell Signaling Technology (U.S.), Genedata AG (Switzerland), Merck KGaA (Germany), Thorlabs, Inc. (U.S.), and Yokogawa Electric Corporation (Japan), among others Browse related reports: Microfluidics Market by Materials (Polymers, Silicon, Glass), Pharmaceuticals (Microreactors, Toxicity Screening, Lab on Chip, Proteomic & Genomic Analysis) Drug Delivery Devices (Microneedles, Micropumps), IVD (POC) - Global Trends & Forecast to 2018 http://www.marketsandmarkets.com/Market-Reports/microfluidics-market-1305.html Optical Imaging Market - Technology Trends and Applications of Optical Coherence Tomography (OCT), Hyper Spectral Imaging (HSI), Near Infrared Spectroscopy (NIRS) and Photo- Acoustic Tomography (PAT) in Clinical Diagnostics, Clinical Research and Life Sciences with Market Landscape Analysis - (2013-2018) http://www.marketsandmarkets.com/Market-Reports/optical-imaging-technologies-market-894.html About MarketsandMarkets MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact: Mr. Rohan North - Dominion Plaza 17304 Preston Road Suite 800, Dallas, TX 75252 Tel: +1-888-600-6441+1-888-600-6441 Email: [email protected] Visit MarketsandMarkets Blog @ http://www.marketsandmarketsblog.com/market-reports/healthcare/biotechnology Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarketsCallSend SMSAdd to SkypeYou'll need Skype CreditFree via Skype CONTACT: Rohan 8886006441 [email protected] .

(c) 2014 M2 COMMUNICATIONS

[ Back To Homepage ]